The FREND™ FLU A&B is a point-of-care testing (POCT) which can be used to measure Influenza A virus and Influenza B virus in human nasopharyngeal swab specimen.
KEY FEATURES & BENEFITS
- Easy to use
- Accurate test result
- Microfluidic Qualitative Immunoassay
- LIS connectivity (data management)
Microfluidic Qualitative Immunoassay
FREND™ FLU A&B
The FREND™ FLU A&B is designed for the qualitative measurement of Influenza virus and Influenza B virus in human nasopharyngeal swab specimens by fluorescence immunoassay (FIA) using the FREND™ System.
Instructions for use
With just simple steps of operation, the FREND™ system supports quick decision-making.
Performance evaluation
Clinical performance
The total of 411 clinical samples (195 positive and 131 negative) confirmed with RT-PCR were tested with the FREND™ FLU A&B.
Performance evaluation
Agreement
The total of 326 clinical samples (179 positive and 147 negative) confirmed with Predicate device were tested with the FREND™ FLU A&B.
Package
20 tests